Impact of missense mutations on biosynthesis of myeloperoxidase

被引:14
作者
Nauseef, WM
McCormick, S
Goedken, M
机构
[1] Univ Iowa, Dept Med, Iowa City, IA 52422 USA
[2] Univ Iowa, Inflammat Program, Iowa City, IA 52422 USA
[3] Vet Affairs Med Ctr, Dept Med, Iowa City, IA 52422 USA
关键词
D O I
10.1179/135100000101535753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have examined the biosynthesis of normal and mutant forms of myeloperoxidase (MPO) in order to gain insights into the critical features of normal biogenesis of MPO. The expression of wild-type and mutant forms of MPO in a stably transfected cell line devoid of endogenous MPO as well as in established human promyelocytic cell lines has allowed understanding of several features of MPO biosynthesis. It is clear that heme insertion into apoproMPO is necessary for proper folding, egress from the endoplasmic reticulum (ER), and eventual entry into the maturation pathway. In addition, molecular chaperones calreticulin and calnexin interact with normal MPO precursors in a sequential and regulated fashion. Studies of naturally occurring mutants, specifically missense mutations underlying inherited MPO deficiency, and mutations in putatively important residues in MPO have highlighted special features of the ER quality control system in the context of MPO biosynthesis. With identification of additional genotypes of MPO deficiency and the recent solution of MPO crystal structure at 1.8 Angstrom, this approach provides a powerful technique to assess structure-function relationships in MPO that are likely applicable to other members of the family of animal peroxidases.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 60 条
[41]   Pattern of inheritance in hereditary myeloperoxidase deficiency associated with the R569W missense mutation [J].
Nauseef, WM ;
Cogley, M ;
Bock, S ;
Petrides, PE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (02) :264-269
[42]   Quality control in the endoplasmic reticulum: Lessons from hereditary myeloperoxidase deficiency [J].
Nauseef, WM .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (03) :215-221
[43]  
NAUSEEF WM, 1989, BLOOD, V73, P290
[44]  
NAUSEEF WM, 1987, BLOOD, V70, P1143
[45]  
NAUSEEF WM, 1992, BLOOD, V80, P2622
[46]   Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase [J].
Nauseef, WM ;
McCormick, SJ ;
Goedken, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :7107-7111
[47]   An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element [J].
Piedrafita, FJ ;
Molander, RB ;
Vansant, G ;
Orlova, EA ;
Pfahl, M ;
Reynolds, WF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14412-14420
[48]   Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro [J].
Podrez, EA ;
Schmitt, D ;
Hoff, HF ;
Hazen, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1547-1560
[49]   Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease [J].
Reynolds, WF ;
Rhees, J ;
Maciejewski, D ;
Paladino, T ;
Sieburg, H ;
Maki, RA ;
Masliah, E .
EXPERIMENTAL NEUROLOGY, 1999, 155 (01) :31-41
[50]   An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia [J].
Reynolds, WF ;
Chang, E ;
Douer, D ;
Ball, ED ;
Kanda, V .
BLOOD, 1997, 90 (07) :2730-2737